VASTox provides grant to support Duchenne Muscular Dystrophy patient registry
The DMD Registry aims to register every person in the UK with DMD and Becker muscular dystrophy, including detailed clinical and genetic data, in a secure, legally protected database that has been endorsed by senior clinicians, health professionals and researchers. It will be used by these groups to help accelerate the development and delivery of new treatments for Duchenne and Becker muscular dystrophies by providing an easier route to clinical trials in the UK.
Ultimately, this registry will be used by VASTox, and other organisations engaged in the development of therapies for muscular dystrophies, to support Phase II and Phase III clinical trials in the UK. The grant will be used by PPUK to recruit a full-time project manager and to help raise awareness of the registry among clinicians, patients and their families.
The resource will also provide information for families of DMD patients, including the latest developments in research for treatments for DMD, which will enable them to make better decisions about their future medical care needs.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.